About Timothy Brahm
Form D filings for NKore Biotherapeutics in 2023 list Timothy Brahm as director.
Timothy Brahm first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Brahm in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Timothy Brahm works with at each company, as listed on that company's latest Form D.
NKore Biotherapeutics, LLC · Form D, Apr 13, 2023
RB
R Gregory Brophy
Chief Executive Officer and director
TR
Tracy Ryan
Executive officer and director
DR
Diederik van der Reijt
Director